19th International Workshop on Clinical Pharmacology, 22–24 May 2018, Baltimore
29 June 2018. Related: Conference reports.
The19th International Workshop on Clinical Pharmacology was held from 22–24 May 2018 in Baltimore.
Some materials from the conference, including the programme and slides for many of the oral presentations are posted online.
Abstract book is not yet online:
Reports included in this issue of HTB.
- Unbound dolutegravir plasma concentrations unchanged in pregnancy and standard dosing crosses the placenta in placental perfusion model
- Etravirine dispersible paediatric tablet has greater bioavailability when dispersed in water compared to swallowed whole
- Reduced exposure to elvitegravir in pregnancy: results from the PANNA Network
- Rifabutin dosed 2.5 mg/kg daily with lopinavir/r in children achieves comparable exposure to adults
- No clinically relevant reduction in oral cabotegravir when co-administered with rifabutin
- Boosted darunavir 800/100 mg twice daily might overcome interaction with rifampicin
- Efavirenz side effects and other drug-drug interactions are common in Ugandan cohort